- Home
- VALN vs EQBK Comparison
VALN vs EQBK Comparison
Compare VALN & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALN
- EQBK
- Stock Information
- Founded
- VALN 2012
- EQBK 2002
- Country
- VALN France
- EQBK United States
- Employees
- VALN N/A
- EQBK N/A
- Industry
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- EQBK Major Banks
- Sector
- VALN Health Care
- EQBK Finance
- Exchange
- VALN Nasdaq
- EQBK Nasdaq
- Market Cap
- VALN 820.0M
- EQBK 800.2M
- IPO Year
- VALN 2021
- EQBK 2015
- Fundamental
- Price
- VALN $9.43
- EQBK $43.81
- Analyst Decision
- VALN Strong Buy
- EQBK Buy
- Analyst Count
- VALN 4
- EQBK 6
- Target Price
- VALN $15.75
- EQBK $47.80
- AVG Volume (30 Days)
- VALN 21.9K
- EQBK 70.6K
- Earning Date
- VALN 11-20-2025
- EQBK 10-14-2025
- Dividend Yield
- VALN N/A
- EQBK 1.66%
- EPS Growth
- VALN N/A
- EQBK N/A
- EPS
- VALN N/A
- EQBK 1.00
- Revenue
- VALN $211,089,992.00
- EQBK $186,035,000.00
- Revenue This Year
- VALN $6.86
- EQBK $15.54
- Revenue Next Year
- VALN $11.85
- EQBK $37.88
- P/E Ratio
- VALN N/A
- EQBK $43.34
- Revenue Growth
- VALN 13.48
- EQBK 17.93
- 52 Week Low
- VALN $3.62
- EQBK $34.11
- 52 Week High
- VALN $12.25
- EQBK $49.55
- Technical
- Relative Strength Index (RSI)
- VALN 56.66
- EQBK 67.01
- Support Level
- VALN $8.53
- EQBK $40.22
- Resistance Level
- VALN $8.92
- EQBK $43.94
- Average True Range (ATR)
- VALN 0.33
- EQBK 1.01
- MACD
- VALN 0.07
- EQBK 0.25
- Stochastic Oscillator
- VALN 89.57
- EQBK 98.25
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.